. Author manuscript; available in PMC: 2017 Jul 1.

Published in final edited form as: J Acquir Immune Defic Syndr. 2016 Jul 1;72(3):297–303. doi: 10.1097/QAI.0000000000000970

Table 1.

Demographic and clinical characteristics of enrolled patients, stratified by empiric TB treatment status

Characteristics (n, %)	No Empiric TB Treatment (n=505)	Empiric TB Treatment (n=126)	p-Value
Women	296 (59)	70 (56)	0.53
Median age (IQR), years	33 (28-40)	32 (28-39)	0.36
Median CD4+ count (IQR), cells/μL	72 (20-205)	86 (26-207)	0.44
Antiretroviral therapy on admission	113 (22)	20 (16)	0.11
CTX prophylaxis	275 (54)	72 (57)	0.59
Antibiotics for current illness	307 (61)	74 (59)	0.67
Productive cough	459 (91)	99 (79)	<0.001
Dyspnea	298 (59)	73 (58)	0.83
Weight loss (>5 kg)	469 (93)	119 (94)	0.53
Danger signs	248 (49)	74 (59)	0.053
Fever (T>39°C)	27 (5)	13 (10)	0.041
Tachycardia (HR>120)	105 (21)	42 (33)	0.003
Tachypnea (RR>30)	195 (39)	49 (39)	0.96
Hypoxia (SpO₂≤93%)	170 (34)	46 (37)	0.55
Chest radiograph consistent with TB	277 (65)^*	73 (63)^†	0.78
Mycobacterial culture-positive	108 (23)	59 (52)	<0.001

Abbreviations: CTX, co-trimoxazole; HR, heart rate; IQR, interquartile ratio; RR, respiratory rate; SpO₂, Oxygen saturation; T, Temperature; TB, tuberculosis.

Legend:

Missing 78 observations

^†

Missing 11 observations